Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Rhabdomyosarcoma, child
Stage/Subtype:  previously untreated childhood rhabdomyosarcoma
Trial Type:  Treatment
Results 1-3 of 3 for your search:
Start Over
Combination Chemotherapy with or without Temsirolimus in Treating Patients with Intermediate Risk Rhabdomyosarcoma
Status: Temporarily closed
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Age: 40 and under
Trial IDs: ARST1431, NCI-2015-01644, NCT02567435
Chemotherapy, Surgery, and Radiation Therapy in Treating Patients with Newly Diagnosed or Localized Rhabdomyosarcoma
Status: Active
Phase: Phase II
Type: Treatment
Age: Under 22
Trial IDs: RMS13, NCI-2013-00913, NCT01871766
Cabozantinib-S-Malate in Treating Younger Patients with Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Not yet active
Phase: Phase II
Type: Treatment
Age: 2 to 30
Trial IDs: ADVL1622, NCI-2016-01258, NCT02867592
Start Over